Effect of nasal corticosteroid on cacosmia after COVID-19
Background: Olfactory disorders may be an isolated symptom of (COVID-19) infection. Multiple treatment modalities have been attempted to treat them. Objectives: compare the effect of nasal corticosteroid on COVID-19 positive patients aiming to decrease the duration of olfactory qualitative, quanti...
Main Authors: | Usama Taya, Ahmed Gaber AbdElraheem, Nehad Hassan Abdelrahman* |
---|---|
Format: | Article |
Language: | English |
Published: |
South Valley University, Faculty of Medicine
2022-07-01
|
Series: | SVU - International Journal of Medical Sciences |
Subjects: | |
Online Access: | https://svuijm.journals.ekb.eg/article_258677.html |
Similar Items
-
Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study
by: Can Tipirdamaz, et al.
Published: (2022-06-01) -
Frequency and Severity of Ear–Nose–Throat (ENT) Symptoms during COVID-19 Infection
by: Natalia Zięba, et al.
Published: (2022-04-01) -
Comparative Study between Intrapolyp Corticosteroid Injection and Oral Corticosteroid in Treatment of Allergic Nasal Polyposis
by: Nehad Hassan Abdelrahman, et al.
Published: (2023-07-01) -
The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis
by: Mona Kabiri, et al.
Published: (2023-09-01) -
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study
by: Sven Saussez, et al.
Published: (2021-06-01)